Clinical laboratories in Donostia, Gasteiz and Bilbao
RPS 131/24Privacy
Combined pathway

Female hormone and fertility profile

May include FSH, LH, estradiol, progesterone, prolactin, TSH, AMH and other tests according to the clinical question and cycle timing.

SampleVenous blood; some tests require a specific cycle day.
FastingUsually not required unless associated tests need it. Prolactin benefits from rest before sampling.
Indicative turnaroundActive ichroma II determinations may be reported rapidly; AMH and specialised tests may be referred.
PathwayCombined pathway
Available atDonostia · Gasteiz · Bilbo

Why it is performed

  • Investigate irregular cycles, absent periods or menopausal symptoms.
  • Guide assessment of ovulation and fertility.
  • Investigate hyperprolactinaemia, polycystic ovary syndrome or other endocrine disorders.
  • Monitor fertility treatment or hormone therapy.

How it is performed

Collection day depends on the hormone. FSH, LH and estradiol are often requested early in the cycle for selected questions; progesterone is timed relative to ovulation rather than a fixed “day 21” for everyone.

Preparation

  • Record the first day of the last period, usual cycle length, contraception and hormone treatment.
  • For prolactin, avoid exercise, breast stimulation and intense stress; rest 15–30 minutes if instructed.
  • Report possible pregnancy, breastfeeding, biotin and medication.
  • Do not interpret a hormone without cycle day and method.

How Askabide processes it

Combined pathway

FSH, LH, estradiol, prolactin and other hormones may be processed by ichroma II fluorescence immunoassay when Askabide keeps the cartridge active and validated. AMH, progesterone and other tests are local only when implemented; otherwise referred.

Part is performed at Askabide and another phase or confirmation is processed externally.

Results and indicative intervals

Intervals vary by method, analyser, reagent, units, age, sex, pregnancy, menstrual-cycle phase and reference population. The valid interval is the one printed on the laboratory report.
Parameter or resultIndicative referenceHow it is interpreted
FSH, follicular phase≈3–10 UI/LMay rise with reduced ovarian reserve or menopause, but a single value does not measure fertility by itself.
LH, follicular phase≈2–12 UI/LPeaks around ovulation; range depends strongly on timing.
Estradiol, follicular phase≈20–350 pg/mLThe interval is broad and changes throughout the cycle.
Progesterone, follicular phaseHabitualmente <1,5 ng/mLShould rise after ovulation; timing is crucial.
Progesterone, luteal phaseAproximadamente 3–25 ng/mLA single value is limited for assessing luteal quality because secretion is pulsatile.
Prolactin≈5–25 ng/mL en mujer no gestanteStress, sleep, pregnancy, breastfeeding and medicines may raise it.
AMHAge- and method-dependentProvides information on follicular reserve; it does not guarantee pregnancy or egg quality.

Important limitations

  • Intervals change markedly with cycle phase, pregnancy, age and treatment.
  • Low ovarian reserve is not the same as infertility and high AMH does not guarantee fertility.
  • Polycystic ovary syndrome is not diagnosed with a single hormone.
  • Raised prolactin should be repeated under suitable conditions and macroprolactin or secondary causes considered when appropriate.
This website provides general information about clinical laboratory tests and diagnostic procedures. It does not replace an individual clinical assessment or the interpretation of the report issued by the laboratory.
Published reference values are indicative and may vary according to the method, equipment, units and individual characteristics.